Intralasionale methotrexat-injektion. Eine wirkungsvolle, zeit- und kostensparende therapiealternative bei operativ schwierig zu behandelnden keratoakanthomen

R. Remling; M. Mempel; N. Schnopp; D. Abeck; J. Ring

doi:10.1007/s001050051180

Intralasionale methotrexat-injektion. Eine wirkungsvolle, zeit- und kostensparende therapiealternative bei operativ schwierig zu behandelnden keratoakanthomen

Translated title of the contribution: Intralesional methotrexate injection. An effective time- and cost-saving therapy alternative in keratoacanthomas that are difficult to treat operatively

R. Remling
, M. Mempel
, N. Schnopp
, D. Abeck
, J. Ring

TUM Emeriti of Excellence

Technical University of Munich

Research output: Contribution to journal › Article › peer-review

14 Scopus citations

Abstract

A 53 year old female patient developed a keratoacanthoma, present on the left side of her nose for two months. After repeated unsuccessful trials with cryotherapy, she was treated with intralesional injection of methotrexate performed twice with a weekly internal. This led to complete resolution within 5 weeks. Although controlled studies on the effect of methotrexate in keratoacanthoma are not available, the rapid regression and the good cosmetic result suggest that this therapy may play a beneficial role in treating these lesions especially in problem locations.

Translated title of the contribution	Intralesional methotrexate injection. An effective time- and cost-saving therapy alternative in keratoacanthomas that are difficult to treat operatively
Original language	German
Pages (from-to)	612-614
Number of pages	3
Journal	Hautarzt
Volume	51
Issue number	8
DOIs	https://doi.org/10.1007/s001050051180
State	Published - 2000

Access to Document

10.1007/s001050051180

Cite this

@article{3376d9002ae24c159c5b0c7931693099,

title = "Intralasionale methotrexat-injektion. Eine wirkungsvolle, zeit- und kostensparende therapiealternative bei operativ schwierig zu behandelnden keratoakanthomen",

abstract = "A 53 year old female patient developed a keratoacanthoma, present on the left side of her nose for two months. After repeated unsuccessful trials with cryotherapy, she was treated with intralesional injection of methotrexate performed twice with a weekly internal. This led to complete resolution within 5 weeks. Although controlled studies on the effect of methotrexate in keratoacanthoma are not available, the rapid regression and the good cosmetic result suggest that this therapy may play a beneficial role in treating these lesions especially in problem locations.",

keywords = "Intralesional injection, Keratoacanthoma, Methotrexate",

author = "R. Remling and M. Mempel and N. Schnopp and D. Abeck and J. Ring",

year = "2000",

doi = "10.1007/s001050051180",

language = "Deutsch",

volume = "51",

pages = "612--614",

journal = "Hautarzt",

issn = "0017-8470",

publisher = "Springer Medizin",

number = "8",

}

TY - JOUR

T1 - Intralasionale methotrexat-injektion. Eine wirkungsvolle, zeit- und kostensparende therapiealternative bei operativ schwierig zu behandelnden keratoakanthomen

AU - Remling, R.

AU - Mempel, M.

AU - Schnopp, N.

AU - Abeck, D.

AU - Ring, J.

PY - 2000

Y1 - 2000

N2 - A 53 year old female patient developed a keratoacanthoma, present on the left side of her nose for two months. After repeated unsuccessful trials with cryotherapy, she was treated with intralesional injection of methotrexate performed twice with a weekly internal. This led to complete resolution within 5 weeks. Although controlled studies on the effect of methotrexate in keratoacanthoma are not available, the rapid regression and the good cosmetic result suggest that this therapy may play a beneficial role in treating these lesions especially in problem locations.

AB - A 53 year old female patient developed a keratoacanthoma, present on the left side of her nose for two months. After repeated unsuccessful trials with cryotherapy, she was treated with intralesional injection of methotrexate performed twice with a weekly internal. This led to complete resolution within 5 weeks. Although controlled studies on the effect of methotrexate in keratoacanthoma are not available, the rapid regression and the good cosmetic result suggest that this therapy may play a beneficial role in treating these lesions especially in problem locations.

KW - Intralesional injection

KW - Keratoacanthoma

KW - Methotrexate

UR - https://www.scopus.com/pages/publications/0033623309

U2 - 10.1007/s001050051180

DO - 10.1007/s001050051180

M3 - Artikel

C2 - 10997318

AN - SCOPUS:0033623309

SN - 0017-8470

VL - 51

SP - 612

EP - 614

JO - Hautarzt

JF - Hautarzt

IS - 8

ER -

Intralasionale methotrexat-injektion. Eine wirkungsvolle, zeit- und kostensparende therapiealternative bei operativ schwierig zu behandelnden keratoakanthomen

Abstract

Access to Document

Other files and links

Fingerprint

Cite this